What Nuo Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 0 | 1 |
| Total trades | 4 | 18 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 17,546 | 517,041 |
| Disposed | 0 | 488,322 |
| Net activity | +17,546 | +28,719 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Jorden David Emerson | CEO/CFO | Aug 28 | Open-market buy · P | +7,984 | $1.09 | +$8.69K | 2,070,000 |
| Jorden David Emerson | CEO/CFO | Aug 28 | Grant / award · A | +7,984 | $1.09 | +$8.69K | 2,070,000 |
| Jorden David Emerson | CEO/CFO | Aug 27 | Open-market buy · P | +789 | $1.07 | +$844 | 2,062,016 |
| Jorden David Emerson | CEO/CFO | Aug 27 | Grant / award · A | +789 | $1.07 | +$844 | 2,062,016 |
| Winzer C Eric | Director | Jun 30 | Withheld — tax / exercise cost · F | −39,604 | $1.01 | −$40K | 173,050 |
| Winzer C Eric | Director | Jun 30 | Exercise / conversion · M | +40,000 | $1.00 | +$40K | 212,654 |
| Pittman Scott M. | Director | Jun 30 | Withheld — tax / exercise cost · F | −39,604 | $1.01 | −$40K | 5,400,396 |
| Pittman Scott M. | Director | Jun 30 | Exercise / conversion · M | +40,000 | $1.00 | +$40K | 5,440,000 |
| Jorden David Emerson | CEO/CFO | Jun 30 | Withheld — tax / exercise cost · F | −160,892 | $1.01 | −$163K | 2,061,227 |
| Jorden David Emerson | CEO/CFO | Jun 30 | Exercise / conversion · M | +162,500 | $1.00 | +$163K | 2,222,119 |
| Jorden David Emerson | CEO/CFO | Jun 05 | Grant / award · A | +13,245 | $1.10 | +$14.5K | 2,085,000 |
| Jorden David Emerson | CEO/CFO | Jan 01 | Withheld — tax / exercise cost · F | −25,381 | $1.97 | −$50K | 2,046,374 |
| Jorden David Emerson | CEO/CFO | Jan 01 | Exercise / conversion · M | +125,000 | $0.40 | +$50K | 2,071,755 |
| Winzer C Eric | Director | Dec 17 | Withheld — tax / exercise cost · F | −13,750 | $2.00 | −$27.5K | 172,654 |
| Winzer C Eric | Director | Dec 17 | Exercise / conversion · M | +68,750 | $0.40 | +$27.5K | 186,404 |
| Mintz Paul | Director | Dec 09 | Withheld — tax / exercise cost · F | −9,091 | $2.20 | −$20K | 108,294 |
| Mintz Paul | Director | Dec 09 | Exercise / conversion · M | +50,000 | $0.40 | +$20K | 117,385 |
| Jorden David Emerson | CEO/CFO | Nov 28 | Open-market sale · S | −200,000 | $1.50 | −$300K | 1,946,755 |
| Jorden David Emerson | CEO/CFO | Aug 01 | Withheld — tax / exercise cost · F | −21,313 | $1.74 | −$37.1K | 2,146,755 |
| Jorden David Emerson | CEO/CFO | Aug 01 | Exercise / conversion · M | +92,710 | $0.40 | +$37.1K | 2,168,068 |
Loading...
